{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:03:58Z","timestamp":1784574238517,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007312","name":"Cleveland Clinic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ygyno.2020.09.039","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T01:42:03Z","timestamp":1602294123000},"page":"712-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening"],"prefix":"10.1016","volume":"159","author":[{"given":"Caitlin","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Priyadarshini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Marquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Michener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam M.","family":"AlHilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.09.039_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal Cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/8.4.661","article-title":"MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers","volume":"8","author":"Simpkins","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0020","series-title":"Frequency and Prognostic Impact of Microsatellite Instability in a Large Population-Based Study of Endometrial Carcinomas 1","author":"Macdonald","year":"2000"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0025","series-title":"Frequency and Prognostic Impact of Microsatellite Instability in a Large Population-Based Study of Endometrial Carcinomas 1","author":"Macdonald","year":"2000"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of gynecologic oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0035","unstructured":"G. Getz, S.B. Gabriel, K. Cibulskis, E. Lander, A. Sivachenko, C. Sougnez, M. Lawrence, C. Kandoth, D. Dooling, R. Fulton, L. Fulton, J. Kalicki-Veizer, M.D. McLellan, M. O'Laughlin, H. Schmidt, R.K. Wilson, K. Ye, D. Li, A. Ally, M. Balasundaram, I. Birol, Y.S.N. Butterfield, R. Carlsen, C. Carter, A. Chu, E. Chuah, H.J.E. Chun, N. Dhalla, R. Guin, C. Hirst, R.A. Holt, S.J.M. Jones, D. Lee, H.I. Li, M.A. Marra, M. Mayo, R.A. Moore, A.J. Mungall, P. Plettner, J.E. Schein, P. Sipahimalani, A. Tam, R.J. Varhol, A. Gordon Robertson, A.D. Cherniack, I. Pashtan, G. Saksena, R.C. Onofrio, S.E. Schumacher, B. Tabak, S.L. Carter, B. Hernandez, J. Gentry, H.B. Salvesen, K. Ardlie, W. Winckler, R. Beroukhim, M. Meyerson, A. Hadjipanayis, S. Lee, H.S. Mahadeshwar, P. Park, A. Protopopov, X. Ren, S. Seth, X. Song, J. Tang, R. Xi, L. Yang, Z. Dong, R. Kucherlapati, L. Chin, J. Zhang, J. Todd Auman, S. Balu, T. Bodenheimer, E. Buda, D. Neil Hayes, A.P. Hoyle, S.R. Jefferys, C.D. Jones, S. Meng, P.A. Mieczkowski, L.E. Mose, J.S. Parker, C.M. Perou, J. Roach, S. Yan, J. v. Simons, M.G. Soloway, D. Tan, M.D. Topal, S. Waring, J. Wu, K.A. Hoadley, S.B. Baylin, M.S. Bootwalla, P.H. Lai, T.J. Triche, D.J. van den Berg, D.J. Weisenberger, P.W. Laird, H. Shen, J. Cho, D. Dicara, S. Frazer, D. Heiman, R. Jing, P. Lin, W. Mallard, P. Stojanov, D. Voet, H. Zhang, L. Zou, M. Noble, S.M. Reynolds, I. Shmulevich, B. Arman Aksoy, Y. Antipin, G. Ciriello, G. Dresdner, J. Gao, B. Gross, A. Jacobsen, M. Ladanyi, B. Reva, C. Sander, R. Sinha, S. Onur Sumer, B.S. Taylor, E. Cerami, N. Weinhold, N. Schultz, R. Shen, S. Benz, T. Goldstein, D. Haussler, S. Ng, C. Szeto, J. Stuart, C.C. Benz, C. Yau, W. Zhang, M. Annala, B.M. Broom, T.D. Casasent, Z. Ju, H. Liang, G. Liu, Y. Lu, A.K. Unruh, C. Wakefield, J.N. Weinstein, N. Zhang, Y. Liu, R. Broaddus, R. Akbani, G.B. Mills, C. Adams, T. Barr, A.D. Black, J. Bowen, J. Deardurff, J. Frick, J.M. Gastier-Foster, T. Grossman, H.A. Harper, M. Hart-Kothari, C. Helsel, A. Hobensack, H. Kuck, K. Kneile, K.M. Leraas, T.M. Lichtenberg, C. McAllister, R.E. Pyatt, N.C. Ramirez, T.R. Tabler, N. Vanhoose, P. White, L. Wise, E. Zmuda, N. Barnabas, C. Berry-Green, V. Blanc, L. Boice, M. Button, A. Farkas, A. Green, J. MacKenzie, D. Nicholson, S.E. Kalloger, C. Blake Gilks, B.Y. Karlan, J. Lester, S. Orsulic, M. Borowsky, M. Cadungog, C. Czerwinski, L. Huelsenbeck-Dill, M. Iacocca, N. Petrelli, B. Rabeno, G. Witkin, E. Nemirovich-Danchenko, O. Potapova, D. Rotin, A. Berchuck, M. Birrer, P. Disaia, L. Monovich, E. Curley, J. Gardner, D. Mallery, R. Penny, S.C. Dowdy, B. Winterhoff, L. Dao, B. Gostout, A. Meuter, A. Teoman, F. Dao, N. Olvera, F. Bogomolniy, K. Garg, R.A. Soslow, M. Abramov, J.M.S. Bartlett, S. Kodeeswaran, J. Parfitt, F. Moiseenko, B.A. Clarke, M.T. Goodman, M.E. Carney, R.K. Matsuno, J. Fisher, M. Huang, W. Kimryn Rathmell, L. Thorne, L. van Le, R. Dhir, R. Edwards, E. Elishaev, K. Zorn, P.J. Goodfellow, D. Mutch, A.B. Kahn, D.W. Bell, P.M. Pollock, C. Wang, D. Wheeler, E. Shinbrot, A. Gordon Robertson, L. Ding, C. Blake Gilks, E.R. Mardis, B. Ayala, A.L. Chu, M.A. Jensen, P. Kothiyal, T.D. Pihl, J. Pontius, D.A. Pot, E.E. Snyder, D. Srinivasan, K.R. Mills Shaw, M. Sheth, T. Davidsen, G. Eley, M.L. Ferguson, L. Yang, M.S. Guyer, B.A. Ozenberger, H.J. Sofia, A. Gordon Robertson, D.A. Levine, Integrated genomic characterization of endometrial carcinoma, Nature. 497 (2013) 67\u201373. doi:https:\/\/doi.org\/10.1038\/nature12113."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0040","doi-asserted-by":"crossref","unstructured":"P. M\u00f8ller, T. Sepp\u00e4l\u00e4, I. Bernstein, E. Holinski-Feder, P. Sala, D.G. Evans, A. Lindblom, F. Macrae, I. Blanco, R. Sijmons, J. Jeffries, H. Vasen, J. Burn, S. Nakken, E. Hovig, E.A. R\u00f8dland, K. Tharmaratnam, W.H. de Vos Tot Nederveen Cappel, J. Hill, J. Wijnen, K. Green, F. Lalloo, L. Sunde, M. Mints, L. Bertario, M. Pineda, M. Navarro, M. Morak, L. Renkonen-Sinisalo, I.M. Frayling, J.P. Plazzer, K. Pylvanainen, J.R. Sampson, G. Capella, J.P. Mecklin, G. M\u00f6slein, Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: First report from the prospective Lynch syndrome database, Gut. 66 (2017) 464\u2013472. doi:https:\/\/doi.org\/10.1136\/gutjnl-2015-309675.","DOI":"10.1136\/gutjnl-2015-309675"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","article-title":"Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations","volume":"75","author":"Barrow","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0050","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","article-title":"Systematic review of microsatellite instability and colorectal cancer prognosis","volume":"23","author":"Popat","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10689-013-9664-5","article-title":"Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention","volume":"12","author":"Lu","year":"2013","journal-title":"Familial Cancer"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1091-255X(98)80105-4","article-title":"Cumulative incidence of colorectal and Extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal Cancer","volume":"2","author":"Lin","year":"1998","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0070","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2017.07.003","article-title":"Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival","volume":"146","author":"Cosgrove","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0075","doi-asserted-by":"crossref","unstructured":"P.J. Goodfellow, C.C. Billingsley, H.A. Lankes, S. Ali, D.E. Cohn, R.J. Broaddus, N. Ramirez, C.C. Pritchard, H. Hampel, A.S. Chassen, L. v. Simmons, A.P. Schmidt, F. Gao, L.A. Brinton, F. Backes, L.M. Landrum, M.A. Geller, P.A. DiSilvestro, M.L. Pearl, S.B. Lele, M.A. Powell, R.J. Zaino, D. Mutch, Combined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for Lynch syndrome screening in endometrial cancers from GOG210: An NRG Oncology and Gynecologic Oncology Group study, Journal of Clinical Oncology. 33 (2015) 4301\u20134308. doi:https:\/\/doi.org\/10.1200\/JCO.2015.63.9518.","DOI":"10.1200\/JCO.2015.63.9518"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0080","doi-asserted-by":"crossref","unstructured":"D.T. Le, J.N. Uram, H. Wang, B.R. Bartlett, H. Kemberling, A.D. Eyring, A.D. Skora, B.S. Luber, N.S. Azad, D. Laheru, B. Biedrzycki, R.C. Donehower, A. Zaheer, G.A. Fisher, T.S. Crocenzi, J.J. Lee, S.M. Duffy, R.M. Goldberg, A. de La Chapelle, M. Koshiji, F. Bhaijee, T. Huebner, R.H. Hruban, L.D. Wood, N. Cuka, D.M. Pardoll, N. Papadopoulos, K.W. Kinzler, S. Zhou, T.C. Cornish, J.M. Taube, R.A. Anders, J.R. Eshleman, B. Vogelstein, L.A. Diaz, PD-1 blockade in tumors with mismatch-repair deficiency, New England Journal of Medicine. (2015). doi:https:\/\/doi.org\/10.1056\/NEJMoa1500596.","DOI":"10.1056\/NEJMoa1500596"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0085","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaoncol.2015.2151","article-title":"Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1","volume":"1","author":"Howitt","year":"2015","journal-title":"JAMA Oncology."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0090","doi-asserted-by":"crossref","unstructured":"V. Makker, M.H. Taylor, C. Aghajanian, A. Oaknin, J. Mier, A.L. Cohn, M. Romeo, R. Bratos, M.S. Brose, C. DiSimone, M. Messing, D.E. Stepan, C.E. Dutcus, J. Wu, E. v. Schmidt, R. Orlowski, P. Sachdev, R. Shumaker, A. Casado Herraez, Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer, Journal of Clinical Oncology. (2020) JCO.19.02627. doi:https:\/\/doi.org\/10.1200\/jco.19.02627.","DOI":"10.1200\/JCO.19.02627"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0095","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMp1709968","article-title":"First FDA approval agnostic of cancer site \u2014 when a biomarker defines the indication","volume":"377","author":"Lemery","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0100","doi-asserted-by":"crossref","unstructured":"D.S. McMeekin, D.L. Tritchler, D.E. Cohn, D.G. Mutch, H.A. Lankes, M.A. Geller, M.A. Powell, F.J. Backes, L.M. Landrum, R. Zaino, R.D. Broaddus, N. Ramirez, F. Gao, S. Ali, K.M. Darcy, M.L. Pearl, P.A. DiSilvestro, S.B. Lele, P.J. Goodfellow, Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology\/Gynecologic Oncology Group Study., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34 (2016) 3062\u20138. doi:https:\/\/doi.org\/10.1200\/JCO.2016.67.8722.","DOI":"10.1200\/JCO.2016.67.8722"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0105","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.AOG.0000239097.42987.0c","article-title":"Improved survival with an intact DNA mismatch repair system in endometrial Cancer","volume":"108","author":"Cohn","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0110","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","article-title":"Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma","volume":"24","author":"Black","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0115","first-page":"417","article-title":"Favorable survival associated with microsatellite instability in endometrioid endometrial cancers","volume":"97","author":"Maxwell","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.critrevonc.2013.03.002","article-title":"Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis","volume":"88","author":"Diaz-Padilla","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0125","doi-asserted-by":"crossref","unstructured":"A. Umar, C.R. Boland, J.P. Terdiman, S. Syngal, A. de la Chapelle, J. R\u00fcschoff, R. Fishel, N.M. Lindor, L.J. Burgart, R. Hamelin, S.R. Hamilton, R.A. Hiatt, J. Jass, A. Lindblom, H.T. Lynch, P. Peltomaki, S.D. Ramsey, M.A. Rodriguez-Bigas, H.F.A. Vasen, E.T. Hawk, J.C. Barrett, A.N. Freedman, S. Srivastava, Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability, Journal of the National Cancer Institute. 96 (2004) 261\u2013268. doi:https:\/\/doi.org\/10.1093\/jnci\/djh034.","DOI":"10.1093\/jnci\/djh034"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0130","doi-asserted-by":"crossref","unstructured":"H.F.A. Vasen, P. Watson, J.P. Mecklin, H.T. Lynch, New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC, in: Gastroenterology, W.B. Saunders, 1999: pp. 1453\u20131456. doi:https:\/\/doi.org\/10.1016\/S0016-5085(99)70510-X.","DOI":"10.1016\/S0016-5085(99)70510-X"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02053699","article-title":"The international collaborative group on hereditary non-polyposis colorectal Cancer (ICG-HNPCC)","volume":"34","author":"Vasen","year":"1991","journal-title":"Dis. Colon rectum"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0140","series-title":"Research Electronic Data Capture (REDCap)-a Metadata-Driven Methodology and Workflow Process for Providing Translational Research Informatics Support, Journal of Biomedical Informatics","author":"Harris","year":"2009"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0145","series-title":"A Phase III Trial of Surgery with or without Adjunctive External Pelvic Radiation Therapy in Intermediate Risk Endometrial Adenocarcinoma: A Gynecologic Oncology Group Study, Gynecologic Oncology","author":"Keys","year":"2004"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0150","doi-asserted-by":"crossref","unstructured":"R.A. Nout, V.T.H.B.M. Smit, H. Putter, I.M. J\u00fcrgenliemk-Schulz, J.J. Jobsen, L.C.H.W. Lutgens, E.M. van der Steen-Banasik, J.W.M. Mens, A. Slot, M.S. Kroese, B.N.F.M. van Bunningen, A.C. Ansink, W.L.J. van Putten, C.L. Creutzberg, Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial, The Lancet. (2010). doi:https:\/\/doi.org\/10.1016\/S0140-6736(09)62163-2.","DOI":"10.1016\/S0140-6736(09)62163-2"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0155","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cncr.31901","article-title":"Mismatch repair deficiency identifies patients with high-intermediate\u2013risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: a prognostic biomarker","volume":"125","author":"Backes","year":"2019","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0160","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"Sargent","year":"2010","journal-title":"Journal of Clinical Oncology\u202f: Official Journal of the American Society of Clinical Oncology."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0165","doi-asserted-by":"crossref","unstructured":"C. Zhang, A. Soochit, J.H. Liu, The impact of lymph node dissection on high risk versus low risk endometrial cancer, Annals of Oncology. 29 (2018) viii341. doi:https:\/\/doi.org\/10.1093\/annonc\/mdy285.161.","DOI":"10.1093\/annonc\/mdy285.161"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0170","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0175","doi-asserted-by":"crossref","unstructured":"S.J. Henley, J.W. Miller, N.F. Dowling, V.B. Benard, L.C. Richardson, Uterine Cancer Incidence and Mortality \u2014 United States, 1999\u20132016, MMWR. Morbidity and Mortality Weekly Report. 67 (2018) 1333\u20131338. doi:10.15585\/mmwr.mm6748a1.","DOI":"10.15585\/mmwr.mm6748a1"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/PGP.0000000000000369","article-title":"Frequent mismatch repair protein deficiency in mixed Endometrioid and clear cell carcinoma of the endometrium","volume":"36","author":"K\u00f6bel","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0185","doi-asserted-by":"crossref","unstructured":"B. Djordjevic, B.A. Barkoh, R. Luthra, R.R. Broaddus, Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: Retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas, in: Modern Pathology, 2013: pp. 1401\u20131412. doi:https:\/\/doi.org\/10.1038\/modpathol.2013.67.","DOI":"10.1038\/modpathol.2013.67"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0190","doi-asserted-by":"crossref","unstructured":"W.J. Koh, N.R. Abu-Rustum, S. Bean, K. Bradley, S.M. Campos, K.R. Cho, H.S. Chon, C. Chu, D. Cohn, M.A. Crispens, S. Damast, O. Dorigo, P.J. Eifel, C.M. Fisher, P. Frederick, D.K. Gaffney, S. George, E. Han, S. Higgins, W.K. Huh, J.R. Lurain, A. Mariani, D. Mutch, C. Nagel, L. Nekhlyudov, A.N. Fader, S.W. Remmenga, R. Kevin Reynolds, T. Tillmanns, S. Ueda, E. Wyse, C.M. Yashar, N.R. McMillian, J.L. Scavone, Uterine Neoplasms, Version 1.2018: Clinical practice guidelines in oncology, JNCCN Journal of the National Comprehensive Cancer Network. (2018). doi:https:\/\/doi.org\/10.6004\/jnccn.2018.0006.","DOI":"10.6004\/jnccn.2018.0006"},{"key":"10.1016\/j.ygyno.2020.09.039_bb0195","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10897-011-9465-7","article-title":"Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of genetic counselors and the collaborative Group of the Americas on inherited colorectal Cancer joint practice guideline","volume":"21","author":"Weissman","year":"2012","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ygyno.2020.09.039_bb0200","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/01.AOG.0000456325.50739.72","article-title":"147: Lynch syndrome","volume":"124","author":"American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No","year":"2014","journal-title":"Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820339494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820339494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:53:43Z","timestamp":1758772423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820339494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0090825820339494"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.039","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}